3-o-(5-Deoxy-beta-D-ribofuranosyl) capecitabine

CAS : 1262133-64-1

Ref. 3D-MAC13364

Informations sur le produit

• Nom: 3-o-(5-Deoxy-beta-D-ribofuranosyl) capecitabine
• Synonymes: pentyl N-[1-[(2R,3S,5R)-4-[(2S,3S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]oxy-3-hydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate

Description

3-O-(5-Deoxy-beta-D-ribofuranosyl) capecitabine is a potent inhibitor of the kinase that is involved in cancer cell growth and proliferation. It has been shown to induce apoptosis in tumor cells by inhibiting protein synthesis and blocking the cell cycle. This analog of capecitabine has been tested on various human cancer cell lines and has demonstrated significant anti-tumor activity. 3-O-(5-Deoxy-beta-D-ribofuranosyl) capecitabine inhibits the activity of kinases that are essential for cancer cell survival, making it a promising candidate for cancer treatment. Additionally, this compound has been found in urine samples from patients undergoing chemotherapy with capecitabine, suggesting that it may be a useful biomarker for monitoring treatment efficacy.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 475.5 g/mol
• Formule: C₂₀H₃₀FN₃O₉
• Degré de pureté: Min. 95%